Clinical trial
Effects of Oxytocin on Cognitive Control in Adults With Attention Deficit/Hyperactivity Disorder
NCT03136263 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Oxytocin on Cognitive Control in Adults With Attention Deficit/Hyperactivity Disorder
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- December 14, 2017
- Completion date
- November 5, 2020
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
attention deficit/hyperactivity disorder